13D/13G Filings - Invus L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-12-09
9:33 pm
Unchanged
2024-12-05 13D Lexicon Pharmaceuticals, Inc.
LXRX
Invus L.P. 136,180,481
37.700%
0
(Unchanged)
Filing
History
2024-07-29
5:44 pm
Sale
2024-07-25 13D Lexicon Pharmaceuticals, Inc.
LXRX
Invus L.P. 136,180,481
37.700%
-38,918,903decrease
(-22.23%)
Filing
History
2024-05-14
5:05 pm
Purchase
2024-05-10 13D Lexicon Pharmaceuticals, Inc.
LXRX
Invus L.P. 175,099,384
48.400%
57,546,100increase
(+48.95%)
Filing
History
2024-03-13
9:20 pm
Unchanged
2024-03-11 13D Lexicon Pharmaceuticals, Inc.
LXRX
Invus L.P. 117,553,284
47.700%
0
(Unchanged)
Filing
History
2023-06-05
5:48 pm
Purchase
2023-05-31 13D Lexicon Pharmaceuticals, Inc.
LXRX
Invus L.P. 117,553,284
48.000%
27,775,050increase
(+30.94%)
Filing
History
2022-08-09
4:31 pm
Purchase
2022-08-05 13D Lexicon Pharmaceuticals, Inc.
LXRX
Invus L.P. 89,778,234
47.600%
2,426,070increase
(+2.78%)
Filing
History
2022-08-01
4:16 pm
Purchase
2022-07-27 13D Lexicon Pharmaceuticals, Inc.
LXRX
Invus L.P. 87,352,164
47.600%
16,173,800increase
(+22.72%)
Filing
History
2021-01-21
4:57 pm
Unchanged
2021-01-11 13D Lexicon Pharmaceuticals, Inc.
LXRX
Invus L.P. 71,178,364
50.300%
0
(Unchanged)
Filing
History
2021-01-05
5:26 pm
Unchanged
2020-12-31 13D Lexicon Pharmaceuticals, Inc.
LXRX
Invus L.P. 71,178,364
50.300%
0
(Unchanged)
Filing
History
2020-12-16
4:40 pm
Purchase
2020-12-11 13D Lexicon Pharmaceuticals, Inc.
LXRX
Invus L.P. 71,178,364
50.300%
10,937,500increase
(+18.16%)
Filing
History